4//SEC Filing
AEOLUS PHARMACEUTICALS, INC. 4
Accession 0001102624-16-003743
CIK 0001261734operating
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:54 PM ET
Size
7.2 KB
Accession
0001102624-16-003743
Insider Transaction Report
Form 4
MCMANUS JOHN L
President & CEO
Transactions
- Award
Incentive Stock Option (right to buy)
2016-03-04+250,000→ 250,000 totalExercise: $0.19From: 2017-03-04Exp: 2026-03-04→ Common Stock (250,000 underlying) - Award
Common Stock
2016-12-28$0.15/sh+25,000$3,750→ 3,767,046.6 total
Footnotes (1)
- [F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the reporting person remains an employee of the company.
Documents
Issuer
AEOLUS PHARMACEUTICALS, INC.
CIK 0001261734
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001261734
Filing Metadata
- Form type
- 4
- Filed
- Dec 29, 7:00 PM ET
- Accepted
- Dec 30, 4:54 PM ET
- Size
- 7.2 KB